When a rare disease suddenly dominates headlines, questions spread quickly and so does anxiety. Over the past few weeks, hantavirus has re-entered the national conversation, leaving many families wondering how concerned they should be. For pediatricians, moments like this can be challenging as they balance public concern with clinical reality, and help families navigate information that is often incomplete, alarming or misleading. In this episode, we take a closer look at hantavirus through an evidence-based pediatric lens including what it is, how transmission occurs, who is truly at risk and what clinicians should know when these questions inevitably enter the exam room.

To create clarity, we are joined by Samuel Dominguez, MD, PhD and Justin Searns, MD. Dr. Dominguez is the Medical Director of the Clinical Microbiology Laboratory, as well as the Associate Medical Director of Infection Control and Prevention at Children's Hospital Colorado. Dr. Searns specializes in pediatric infectious diseases and hospital medicine. Both of these experts teach at the University of Colorado School of Medicine.

Some highlights from this episode include:

Differentiating the different types of hantaviruses based on rodent and region
Outlining the current status of the cruise ship outbreak
Tips and tricks for conversing with worries families
The potential impact on patients

For more information on Children's Colorado, visit: childrenscolorado.org.

[Trailer] Redefining Immunotherapy (Ep. 4): Melanoma Treatment Strategy

Episode Description

Listen On